Sustainability Report

The report presents Dr. Reddy's FY2021 sustainability performance across global pharmaceutical operations, emphasizing access to affordable healthcare and COVID-19 response. It reports a 27% reduction in carbon emissions intensity, 21% renewable power share, water and waste neutrality progress, and a 55% carbon-reduction goal for FY2030. The report also highlights zero workplace fatalities, employee development and inclusion initiatives, and board-level oversight of ESG matters. Sustainability disclosures are prepared in accordance with the GRI Standards and are independently assured by DNV.